2.55% -2.37

바이오앤테크 (BNTX)

개요 뉴스 가격 이력 옵션 체인 BNTX 왜 하락? 토론 예측 배당 이력

왜 BioNTech SE ADR (BNTX) 주가가 하락하고 있습니까?

2024-03-20 거래 세션 동안 BioNTech SE ADR(BNTX) 주식이 5.02% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!

2023-10-16:

Shares of BioNTech Se (BNTX) dropped by 6.38% from $103.58 to $96.97 in the trading on Monday, October 16, 2023. The reasons why BNTX stock down include:

Pfizer's sales outlook cut: BioNTech's partner, Pfizer, decided to slash its full-year sales expectations by $9 billion, citing a shift towards the commercial approval of its Paxlovid COVID treatment and other factors. The impact of Pfizer's news rippled through the pharmaceutical sector, causing declines in the shares of BioNTech.
Downgrade rating: BioNTech received a downgrade from HSBC research analysts on Monday. They changed their rating from Buy to hold in a research report distributed to clients and investors, as reported by Marketbeat.com. Additionally, they revised their price target for the stock from $124.00 to $111.00. This indicates a more neutral stance on BioNTech's prospects, reflecting a potential shift in market sentiment or the analysts' assessment of the company's current position.